Patient Guide: A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 39 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06248619
Status: ACTIVE_NOT_RECRUITING
Condition: Thyroid Eye Disease
Phase: PHASE3

Where You Can Participate

This study is available at 39 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Orland Park, Illinois
  • • Ann Arbor, Michigan
  • • And 36 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease - Join Clinical Trial NCTNCT06248619

How to Join This Clinical Trial - NCTNCT06248619

Learn how to participate in this PHASE3 trial studying an investigational therapy for Thyroid Eye Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Thyroid Eye Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Thyroid Eye Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06248619 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 39 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85712 - United States

Status: Contact for availability

Clinical Research Site

Orland Park, Illinois 60462 - United States

Status: Contact for availability

Clinical Research Site

Ann Arbor, Michigan 48105-1912 - United States

Status: Contact for availability

Clinical Research Site

Henderson, Nevada 89074 - United States

Status: Contact for availability

Clinical Research Site

Somerset, New Jersey 08773 - United States

Status: Contact for availability

Clinical Research Site

Portland, Oregon 97239-3130 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19104-2640 - United States

Status: Contact for availability

Clinical Research Site

Memphis, Tennessee 38103-3452 - United States

Status: Contact for availability

Clinical Research Site

Houston, Texas 77030-4101 - United States

Status: Contact for availability

Clinical Research Site

Seattle, Washington 98104-2433 - United States

Status: Contact for availability

And 29 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Thyroid Eye Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships